Skip to main content
. 2022 Feb;76:102074. doi: 10.1016/j.canep.2021.102074

Table 1.

Characteristics of Million Women Study participants with ovarian cancer by ovarian cancer-specific survival

Death from ovarian cancer
Characteristic No (n = 4525) Yes (n = 8697) All (N = 13,222)
Age at diagnosis, mean (SD) 67.8 (7.3) 67.8 (7.2) 67.8 (7.2)
Follow-up time from diagnosis (years), mean (SD) 8.8 (6.0) 2.2 (2.3) 4.5 (5.1)
Lifestyle factors
Body mass index (kg/m2), mean (SD) 26.2 (4.6) 26.4 (4.8) 26.3 (4.7)
Height (cm), mean (SD) 162.4 (6.6) 162.5 (6.6) 162.5 (6.6)
Socioeconomic status, lower third, % (n) 31 (1382) 33 (2817) 32 (4199)
Tertiary education, % (n) 13 (581) 12 (1020) 12 (1601)
Strenuous exercise ≥once/week, % (n) 40 (1735) 40 (3304) 40 (5039)
Alcohol, > 7 units/ week, % (n) 20 (914) 18 (1565) 19 (2479)
Current smoker, % (n) 19 (791) 19 (1528) 19 (2319)
Reproductive/ hormonal factors
Age at menarche, mean (SD) 13.0 (1.6) 13.0 (1.6) 13.0 (1.6)
Nulliparous, % (n) 15 (674) 13 (1142) 14 (1816)
Ever use of oral contraceptive pill, % (n) 56 (2501) 50 (4266) 52 (6767)
Ever use of menopausal hormones, % (n) 48 (2161) 49 (4211) 49 (6372)
Hysterectomy, % (n) 20 (885) 19 (1681) 20 (2566)
Tubal ligation, % (n) 19 (818) 17 (1474) 18 (2292)
Family history of breast cancer 11 (477) 11 (907) 11 (1384)
Tumour characteristics
Histological type, % (n)
 Serous borderline tumour 11 (479) 0.4 (35) 4 (514)
 Mucinous borderline tumour 13 (594) 0.3 (23) 5 (617)
 Serous carcinoma 36 (1609) 51 (4459) 46 (6068)
 Mucinous carcinoma 8 (352) 3 (225) 4 (577)
 Endometrioid carcinoma 11 (481) 4 (316) 6 (797)
 Clear cell carcinoma 6 (259) 3 (258) 4 (517)
 Carcinosarcoma 2 (76) 3 (300) 3 (376)
 Other/ Unspecified 15 (675) 35 (3081) 28 (3756)
Stage at diagnosis, % (n)
 Stage I 53 (1558) 6 (295) 24 (1853)
 Stage II 10 (287) 5 (228) 7 (515)
 Stage III 29 (848) 59 (2858) 47 (3706)
 Stage IV 9 (265) 31 (1497) 22 (1762)

Notes: Table shows column %. Numbers may not sum to total due to missing data.